Tatiana Zavorotinskaya
Gilead Sciences (United States)(US)Sunesis (United States)(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cancer Mechanisms and Therapy, Peptidase Inhibition and Analysis, Adenosine and Purinergic Signaling, HIV Research and Treatment
Most-Cited Works
- → Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation(2013)161 cited
- → Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers(2014)111 cited
- → Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies(2015)74 cited
- → Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors(2013)53 cited
- → Suppression of a Fusion Defect by Second Site Mutations in the Ecotropic Murine Leukemia Virus Surface Protein(1999)48 cited
- → Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13(2003)46 cited
- → A Point Mutation in the Binding Subunit of a Retroviral Envelope Protein Arrests Virus Entry at Hemifusion(2003)44 cited
- → Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production(2020)42 cited
- → Analysis of the murine ecotropic leukemia virus receptor reveals a common biochemical determinant on diverse cell surface receptors that is essential to retrovirus entry(1996)35 cited
- → Inhibition of prenylated KRAS in a lipid environment(2017)31 cited